Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Dong Lin, Susan L. Ettinger, Sifeng Qu, Hui Xue, Noushin Nabavi, Stephen Yiu Chuen Choi, Robert H. Bell, Fan Mo, Anne M. Haegert, Peter W. Gout, Neil Fleshner, Martin E. Gleave, Michael Pollak, Colin C. Collins, Yuzhuo Wang
Published Feb 9, 2017 · Vol. 8, No. 16 · pp. 25928-25941
Cinzia Bersani, Lars Sivars, Linnea Haeggblom, Sebastian DiLorenzo, Michael Mints, Andreas Ährlund-Richter, Nikolaos Tertipis, Eva Munck-Wikland, Anders Näsman, Torbjörn Ramqvist, Tina Dalianis
Published Feb 9, 2017 · Vol. 8, No. 21 · pp. 35339-35350
Anna-Lena Geißler, Miriam Geißler, Daniel Kottmann, Lisa Lutz, Christiane D. Fichter, Ralph Fritsch, Britta Weddeling, Frank Makowiec, Martin Werner, Silke Lassmann
Published Feb 9, 2017 · Vol. 8, No. 10 · pp. 17164-17190
Adeola O. Adebayo Michael, Nagib Ahsan, Valerie Zabala, Heather Francois-Vaughan, Stephanie Post, Kate E. Brilliant, Arthur R. Salomon, Jennifer A. Sanders, Philip A. Gruppuso
Published Feb 9, 2017 · Vol. 8, No. 16 · pp. 26041-26056